Mauna Kea Technologies

OverviewSuggest Edit

Mauna Kea Technologies is a global medical device company dedicated to the advent of optical biopsy. The company researches, develops and markets innovative tools to visualize and detect cellular abnormalities during endoscopic procedures. Its flagship product, Cellvizio®, a probe-­based Confocal Laser Endomicroscopy (pCLE) system, provides physicians and researchers high-­resolution cellular views of tissue inside the body. Large, international, multi-center clinical trials have demonstrated Cellvizio's ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce costs within a hospital, Cellvizio can be used with almost any endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-­‐Mark for use in the GI tract, biliary and pancreatic ducts and lungs.
TypePublic
Founded2000
HQParis, FR
Websitemaunakeatech.com
Employee Ratings4.2

Latest Updates

Employees (est.) (Dec 2018)100(+3%)
Job Openings2
Share Price (Oct 2017)€4.2 (+10%)

Key People/Management at Mauna Kea Technologies

Sacha Loiseau

Sacha Loiseau

Ph.D. President and CEO. Co-Founder
Christophe Lamboeuf

Christophe Lamboeuf

CFO
François Lacombe

François Lacombe

Ph.D. Chief Scientific Officer
Véronique Dentan

Véronique Dentan

Ph.D. Director of Operations
Dennis Feldman

Dennis Feldman

Executive Vice-President of Sales & Marketing, USA
Aline Criton

Aline Criton

Ph.D. Regulatory and Clinical Affairs and Scientific Communication Director
Show more

Mauna Kea Technologies Office Locations

Mauna Kea Technologies has an office in Paris
Paris, FR (HQ)
9 Rue d'Enghien
Show all (1)

Mauna Kea Technologies Financials and Metrics

Mauna Kea Technologies Revenue

Market capitalization (31-Oct-2017)

102.5m

Closing stock price (31-Oct-2017)

4.2
Mauna Kea Technologies's current market capitalization is €102.5 m.
Show all financial metrics

Mauna Kea Technologies Online and Social Media Presence

Embed Graph

Mauna Kea Technologies News and Updates

Juncker Plan: 22.5 million for Mauna Kea Technologies

Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy platform, and the European Investment Bank (EIB), which is the Bank of the European Union (EU), announce the signing of a €22.5 million loan agreement, supported by the Eur…

Mauna Kea Technologies Frequently Asked Questions

  • When was Mauna Kea Technologies founded?

    Mauna Kea Technologies was founded in 2000.

  • Who are Mauna Kea Technologies key executives?

    Mauna Kea Technologies's key executives are Sacha Loiseau, Christophe Lamboeuf and François Lacombe.

  • How many employees does Mauna Kea Technologies have?

    Mauna Kea Technologies has 100 employees.

  • Who are Mauna Kea Technologies competitors?

    Competitors of Mauna Kea Technologies include Koh Young Technology, Becton Dickinson and Biovotion.

  • Where is Mauna Kea Technologies headquarters?

    Mauna Kea Technologies headquarters is located at 9 Rue d'Enghien, Paris.

  • Where are Mauna Kea Technologies offices?

    Mauna Kea Technologies has an office in Paris.

  • How many offices does Mauna Kea Technologies have?

    Mauna Kea Technologies has 1 office.